Paper · 42145505
Impact of small area-level deprivation on survival outcomes in patients with Cholangiocarcinoma: a population-based multilevel survival analysis.
Lee J and 11 others. Front Public Health, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Impact of small area-level deprivation on survival outcomes in patients with Cholangiocarcinoma: a population-based multilevel survival analysis. Papers, record 42145505. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42145505
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of small area-level deprivation on survival outcomes in patients with Cholangiocarcinoma: a population-based multilevel survival analysis.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholangiocarcinoma | Major topic |
| Bile Duct Neoplasms | Major topic |
| Humans | |
| Male | |
| Female | |
| Aged | |
| Republic of Korea | |
| Middle Aged | |
| Survival Analysis | |
| Socioeconomic Disparities in Health | |
| Adult | |
| Adolescent | |
| Child, Preschool | |
| Infant | |
| Young Adult | |
| Registries | |
| Risk Factors | |
| Infant, Newborn | |
| Low Socioeconomic Status | |
| Proportional Hazards Models |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,561,981 | The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. | JCO Precis Oncol | 2023 | https://conductscience.org/library/papers/37561981 | PubMed |
| 2 | 39,557,933 | An umbrella review of socioeconomic status and cancer. | Nat Commun | 2024 | https://conductscience.org/library/papers/39557933 | PubMed |
| 3 | 40,809,904 | Socioeconomic disparities in incidence, treatment, and survival of intrahepatic cholangiocarcinoma: insights from a nationwide cohort study in Sweden. | Lancet Reg Health Eur | 2025 | https://conductscience.org/library/papers/40809904 | PubMed |
| 4 | 26,679,150 | Regional variations in cancer survival: Impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway. | Int J Cancer | 2016 | https://conductscience.org/library/papers/26679150 | PubMed |
| 5 | 9,845,623 | Clinical presentation, diagnosis and survival of resected distal bile duct cancer. | Dig Surg | 1998 | https://conductscience.org/library/papers/9845623 | PubMed |
| 6 | 22,595,851 | Alcohol consumption and colorectal cancer in a Mediterranean population: a case-control study. | Dis Colon Rectum | 2012 | https://conductscience.org/library/papers/22595851 | PubMed |
| 7 | 38,292,837 | Trends in colorectal cancer incidence according to an increase in the number of colonoscopy cases in Korea. | World J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/38292837 | PubMed |
| 8 | 19,956,367 | Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. | Cancer Res Treat | 2005 | https://conductscience.org/library/papers/19956367 | PubMed |
| 9 | 39,692,215 | Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand. | Cancer Med | 2024 | https://conductscience.org/library/papers/39692215 | PubMed |
| 10 | 20,370,730 | Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy. | J Gastroenterol Hepatol | 2010 | https://conductscience.org/library/papers/20370730 | PubMed |
1 to 10 of 24
See all 24 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42145505
GET https://conductscience.org/api/papers/v1/42145505/references?page=2